The expression of LAG3 and CD62L, which were almost undetectable in hepatic tissue, was evident in primary CRC infiltrating and circulating T cells, respectively, hence excluding the possibility that these antigens could have been damaged by the tissue processing procedure or that their specific antibodies were not properly titrated. The gene discussed is SELL; the disease is colorectal carcinoma.